“Fostering The Culture of Innovation and Excellence”


On June 26th, Medichem participated in a Design Thinking Workshop organized by Ship2B.

In line with Medichem´s Culture of Innovation, the objective was to Think “Even More” Out of the Box and stand out from the ordinary, while filling our R&D pipeline with new ideas and strategies to pursue.

About twenty people from various departments, R&D, Project Management, Business Development and Supply Chain participated, thus ensuring the variety and pertinence of the inputs provided and the workshop´s success.

Many thanks to all for participating!




USP’s Donor Recognition Program would like to recognize Medichem for its contributions…

USP’s Donor Recognition Program would like to recognize Medichem for its contributions during the 2018 calendar year” Says Ronald T. Piervincenzi, Ph.D. USP Chief Executive Officer.

This program recognizes new and modernized monographs that were published in one of USP’s forums or were posted to USP’s website for comment, as well as those reference material donations that have been released as USP Reference Standards.

Medichem has worked extensively with the USP on several products by providing material and comments to the proposed monographs since 1987, and has thereby become a Gold-level donor.

The United States Pharmacopeial Convention (USP) is a nonprofit scientific organization founded in 1820 in Washington, D.C., that develops and disseminates public compendial quality standards for medicines and other articles (Bylaws, Articles II, and VII). USP’s mission is “to improve global health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods.” USP’s primary compendia of standards are the United States Pharmacopeia and the National Formulary (USP–NF).


Ampliación de la Capacidad Productiva / Production Capacity Expansion

Medichem has carried out a project from 2016- till 2017 to expand the production capacity of its plant in Celrà, which has been financed by the Ministry of Industry, Energy and Tourism.

Medichem ha llevado a cabo durante el periodo 2016-2017 un proyecto de ampliación de la capacidad productiva de la planta de Celrà que ha contado con la financiación del Ministerio de Industria, Energía y Turismo.



Durante los años 2015-2017 el proyecto de Medichem ANTAGONISTA DE LA RELAJACIÓN MUSCULAR ha sido cofinanciado por el Fondo Europeo de Desarrollo Regional (FEDER), dentro del Programa Operativo de Crecimiento Inteligente 2014-2020, con el objetivo de potenciar la investigación, el desarrollo tecnológico y la innovación.



  • Chlorhexidine is an antiseptic and antimicrobial often used as an active ingredient in oral rinse.
  • It provides protection against a wide range of bacteria. It kills bacteria by binding to bacteria cell walls.
  • The FDA approved chlorhexidine 0.12% in August 1986 as ANDA 19-028(1)
  • Chlorhexidine, to date is the most potent anti-plaque agent. It is considered gold standard anti plaque agent, against which efficacy of other anti-plaque and anti -gingivitis agents is measured. Its efficacy can be attributed to:
    • Immediate bactericidal action
    • Prolonged bacteriostatic action.
  • The antimicrobial properties of Chlorhexidine are attributed to its bi-cationic molecule.(2)


  • Gingivitis which causes redness, swelling, and bleeding of the gums.  Chlorhexidine gluconate has a positive chemical charge; it is attracted to the negative charge on certain bacteria in the mouth. This attraction affects the bacterial cell membrane and causes increased permeability for immediate antimicrobial activity. Chlorhexidine gluconate is also attracted to negatively charged surfaces on oral tissue. This additional attraction gives chlorhexidine gluconate a sustained action that can help prevent the formation of plaque(3)
  • Periodontitis disease occurs when inflammation or infection of the gums (gingivitis) is allowed to progress without treatment. Chip impregnated with chlorhexidine are used to reduce or eliminate the sub-gingival microorganisms associated with periodontal diseases.(4)
  • Prevention of Early Childhood Caries. Dental plaque is the main source for dental caries and there is no proper vaccine that can affect dental plaques. Studies have demonstrated that chlorhexidine was superior to other indicated products in its ability to maintain low plaque scores(5)(6)
  • Dental traumas, such as subluxation, intrusion associated with pulp exposure are treated with  mechanical decontamination and intracanal medication composed by 2% of chlorhexidine gel.(7)
  • Wisdom tooth extraction. Use of Chlorhexidine (CHX)-based mouthwash immediately before third molar extraction reduces bacteria levels in patients’ blood after the procedure.(8)
  • Ventilator-associated pneumonia (VAP) is the most common nosocomial infection among ventilated patients and is associated with increased mortality and morbidity. Oral chlorhexidine has been used to decontaminate the airway in critically ill patients, as studies suggest a risk reduction in VAP(9)(10)


  1. http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20774-ltr-lab-mr.pdf
  2. 0.2% Chlorhexidine: An effective oral care against Alpha Haemolytic Streptococci Neelam Kumari*, Vinay Kumari, Sembian Nandagopal, Jyoti Serin, Nitin Goel Insan and Vikas Choudhary M. M. College of Nursing Mullana Ambala, Haryana, India(2015)
  3. Chlorhexidine Gluconate. AHFS Drug Information 2005.
  4. evaluation of clinical efficacy of chlorhexidine chip as an adjunct to scaling and root planing in chronic periodontitis patients. Jayant Ambulgekar, Bansi Bhusari, Rizwan Sanadi, Manan Doshi.2014
  5. Comparison of Antibacterial Effect of Fluoride and Chlorhexidine on Two Cariogenic Bacteria: An in Vitro StudyHamid Reza Poureslami, Fereshteh Barkam, Parnian Poureslami, Zahra Salari, Somayeh Salari.2014
  6. Efficacy of Listerine, Meridol and chlorhexidine mouthrinses on plaque, gingivitis and plaque bacteria vitality.Brecx M1, Netuschil L, Reichert B, Schreil G.1990
  7. Pulp Revascularization after Root Canal Decontamination with Calcium Hydroxide and 2% Chlorhexidine Gel. Adriana de Jesus Soares, PhD∗, , , Fernanda Freitas Lins, MSc†, Juliana Yuri Nagata, MSc∗,Brenda Paula Figueiredo de Almeida Gomes, PhD∗, Alexandre Augusto Zaia, PhD∗, Caio Cezar Randi Ferraz, PhD∗, José Flávio Affonso de Almeida, PhD∗, Francisco José de Souza-Filho, PhD∗.2013
  8. Mouthwash may reduce bacteremia after wisdom tooth extractionJournal .Springer Healthcare News.2012
  9. Survey on the use of chlorhexidine and toothpaste as part of oral care in UK ICUs.I Kangesan, F Millinchamp, JV Williams and LA Burrows (2014)
  10. Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. Mary Jo Grap, PhD, RN, ACNPa, , Cindy L Munro, PhD, RN, ANPa, R.K Elswick Jr, PhDa, b, Curtis N Sessler, MD, FCCMc, Kevin R Ward, MDd


Flow Chemistry is a technique involving the use of structured devices, also called microreactor or flow reactors, where reactants are combined and as a result start reacting. Thus making chemical synthesis a time-resolved process.

Flow chemistry is a well-established technique for use at a large scale when manufacturing large quantities of a given material.

The reactants are pumped through pumps or dosing lines and introduced in a flow reactor device with a given volume. The reaction time, also referred as the residence time, is given by the ratio between total flow rate and channels volume.  The ratio between each flow rates gives the reaction stoichiometry. The reactor is generally connected to one or several recirculated baths to control a single or numerous temperature zone. It is characterized by mixing properties and heat exchange properties. Mixing properties depend on various parameters such as channel dimensions, design, hydrodynamics, flow rate and viscosity. Heat exchange rely on material of constructions, dimensions, liquids properties, mixing quality.

The dimension of the equipment channels generally vary from several µm range (micro reactors) up to few millimetres (meso-reactors). These reactors can be made by various materials of construction such as polymers, metal, glass; the latter is more widely used in the chemical industry due to its broader chemical resistance, while maintaining good mechanical strength within broad temperature range. It also offers the same transparency as the round bottom flask used in the laboratory, which may be seen useful during process development. In the past years, SiC reactors have also been developed, enhancing their heat exchange performances and expanding their chemical compatibility. Starting in the early 90´s the increasing number of patent and publications has been traducing the growing interest in this area [1]. Even if implementation of these continuous processes in pharmaceutical manufacturing appears slow [2], today, these flow reactors devices are commercially available since the early lab scale, up to production scale and are widely used to address many chemical reaction [3,4].

What does it offers?

These flow reactors are especially beneficial as they offer better mixing and heat exchange performances compared to traditional batch reactors.

The Mixing quality is a very important characteristic in reactor performance because it precedes reaction. Due to small channel diameters of microreactors, diffusion phenomenon timescale are generally less than 1 second. And depending on the channels pattern design, the ability to efficiently mix reagent flows can be such high that diffusion timescale can be reduced down to milliseconds for multiphase applications, even for meso-reactors with millimetres scale channels [5]. This means that the chemical reaction is then only limited by the inherent reaction kinetic. In many cases, this significant advantage allows a better control on side reaction and impurities formation. In chemical industry, multi-phase applications are generally difficult to scale-up in conventional batch processes as the mixing quality – which is representative of the mass transfer coefficient- generally degrades as the batch vessel size increases. Therefore better consistency of mixing quality at different scale offered by flow reactors opens the door to easier scale-up of such applications.

Efficient heat management is one of the key benefits offered by flow reactors. In a chemical process, any deviation of temperature involves changes in reaction rates of the desired reaction and also side reactions. This could have a negative influence on the selectivity. An insufficient heat removal capacity might also become a serious problem when it results in product degradation due to hot spot or even turn to thermal runaway. As a result, efficient heat transfer performances are mandatory for precise temperature control and effective heat management. This becomes especially critical in cases of fast and highly exothermic reactions. Microreactors –due to small channel dimensions – show a much higher surface to volume ratio compared to conventional batches [6]. Therefore the heat generated by the chemical reaction in the process volume will have a large surface to be released. As a consequence, temperature fluctuation or changes that require time to be adjusted at large batch scale are almost immediate at microscale. Resulting in better temperature control and more efficient heat released management for highly exothermic reaction. Highly exothermic chemical reactions can be then operated at higher concentrations, allowing further process intensification and operational cost saving. On top of that, the small hold-up volume of such flow reactors minimizes the impact in case of run away and makes them intrinsically safer compared to big batch vessels.

Operating pressure is also an important parameter for chemical processes. By design, channel reactors are generally able to handle much higher pressure compared to batch vessel, as admissible pressure is inversely proportional to the diameter. This opens the door in using broader temperature and pressure range compared to batch process, even under supercritical conditions.

Another important parameter of the chemical process is the reaction time. In case of flow reactor it is defined as residence time (average length of time the reacting components stays within the reactor). The inherent advantages of microreactors cited previously allow to considerably reducing the required time to complete the reaction below one minute or even down to seconds. This is highly interesting when running multistep reaction involving hazardous or unstable intermediate (e.g diazonium, organometallics), as the intermediate can be generated in-situ and immediately consumed, hence avoiding accumulation and inventory of such intermediate. In conventional batch equipment, channelling effect, stagnant zones, back mixing, etc. may have an impact on the process performance, such as incomplete conversion, consecutive reaction, undesirable product formation, etc. And the more homogeneous flow pattern within flow reactors (plug flow reactor) significantly attenuates this phenomenon. Thus, a good control of this residence time allows controlling undesired consecutive reactions or product degradation.

All of the above-mentioned advantages make flow reactors interesting devices to improve selectivity, process safety, minimize inventory of intermediates, reduce reaction time and further improve process intensification.

The pharmaceutical industry is well aware of the potential impact of Continuous processing on their current process. And most large pharma companies are working on developing and implementing continuous processes at various scales. Microreactor is a very powerful tool in development stage as it allows generating a lot of experimental conditions in a raw and in a short time period once, technical hurdle related to precipitation and solid handling, is addressed. However scaling-up microreactor technology to pilot or industrial scale raises new challenges.

The upcoming question is “How to maintain the inherent advantages of those microreactors due to channels dimension when moving to a bigger scale?”.

How to scale-up?

In the course of many years, microreactors scale-up approach was the numbering-up [7]. It consisted in optimizing the reaction in one system and then parallelizing the required number of reactor to address the desired throughput. This safe-by design approach is interesting but faced some limitations related to fluid distribution challenges when several tenths or hundreds units would have to be parallelized, and also associated cost. Resulting in it only being reasonable when limited number of units would be required. But today, some equipment manufacturer propose units at pilot and industrial scale with good scale-up rules, maintaining similar performances from lab to production [8].

What´s about Medichem experience in Flow?

Following scale-up issue faced using conventional equipment on an organo-metallic application. Medichem investigated the use of flow reactor technologies to address this particular point. This step was the opportunity to even shorten the residence time down to few seconds and increase the operating temperature of this cryogenic application compared to the preliminary results. multipurpose production reactor at plant scale.


[1] Review on Patents in Microreactor and Micro Process Engineering pp.1-16 Volker Hessel, Christoph Knobloch, Holger Lowe Recent Patents on Chemical Engineering (2008), vol. 1, Iss.1.

[2] Continuous Processing in the Manufacture of Active Pharmaceutical Ingredients and Finished Dosage Forms: An Industry Perspective Peter Poechlauer, Julie Manley, Rinus Broxterman, Björn Gregertsen, and Mats Ridemark. Org. Process Res. Dev. (2012), 16, 1586−1590.

[3] Microreactors in Organic Synthesis & Catalysis, T. Wirth, Wiley-VCH Verlag, (2007)

[4] Flash Chemistry: Fast Organic Synthesis in Microsystems, Jun-ichi Yoshida, Wiley & Sons, (2008).

[5] A. Woitalka et al. / Chemical Engineering Science (2014), 116, 1–8.

[6] Control of hot spots in plug flow reactors, I. Karafyllis, P. Daoutidis, Computers & Chemical Engineering (2002) Vol.26, Iss. 7–8, 1087–1094

[7] Enabling Continuous-Flow Chemistry in Microstructured Devices for Pharmaceutical and Fine-Chemical Production, Kockmann, N.; Gottsponer, M.; Zimmermann, B.; Roberge, D.M. Chem. Eur. J. (2008), 14, 7470.

[8] From laboratory to production: A seamless scale up, J. Jorda, A. Vizza, Spec. Chem. Mag. (2012), 32, 11, 19-21.